AnnouncementDetails

Actions

The National Medical Care Co. Announces the appointment of the Chairman, Vice Chairman, Managing Director, Secretary, and representatives of the company to the Capital Market Authority, and the formation of its committees

Element ListExplanation
Announcement Detail Reference to the results of Ordinary General Assembly Meeting held on Tuesday 6-9-2022 corresponding to 10-2-1444 AH, which included the election of a board of directors for the new term starting on 15-9-2022 AD for three years which expires on 14-09-2025 AD

The national medical company announces the decision of the board of Directors at its first meeting of the new board on 15-9-2022 corresponding to 19-2-1444 AH, which includes the appointment of the Chairman of the Board of Directors, the Vice-President, the managing Director, the secretary, and the formation of committees, as follows:

First: The Council decided to appoint:

• Mr. Saad bin Abdulmohsen Al-Fadly (Chairman of the Board of Directors)

• Mr. Michael Davis (Vice Chairman)

• Dr. Abdulaziz bin Saleh Al-Obaid (Managing Director)

Second: The company's representatives have been appointed to the Capital Market Authority, and they are:

• Mr. Saad bin Abdulmohsen Al-Fadly

• Dr. Abdulaziz bin Saleh Al-Obaid

Third: A Secretary to the Board of Directors has been appointed Mr.Adel Attallah AlJabrti

Fourth: Formation of the Executive Committee from the following members:

• Mr. Ahmed bin Wazaa Al-Qahtani

• Mr. Michael Davis

• Dr. Abdulaziz bin Saleh Al-Obaid

• Mr. Sami bin Suliman Al-Khashan

Fifth: Formation of the Nominations and Remunerations Committee from the following members:

• Mr. Saad bin Abdulmohsen Al-Fadly

• Mr. Bashar bin Abdulaziz AbalKhail

• Mr. Mai Bint Muhammad Al-Hoshan

• Mr. Badr bin Fahad Al-Athel

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Profile

Actions

Company Profile

Summary

Last Price Net Change
0.0 0.0 (0.0%)
Value Traded (SAR) Volume Traded
0 0